Liver Applications - Fibrosis & NASH | InSphero

3D InSight™ Liver Disease models are based on 3D InSight™ Human Liver Microtissue technology.  They are engineered to incorporate all the primary human liver cells required to recapitulate the disease state, including primary hepatocytes, Kupffer cells and liver endothelial cells.  These advanced models are designed for high throughput screening and efficacy testing of drugs for metabolic diseases of the liver, and are ideal for long-term dosing protocols necessary to gauge effectiveness of novel compounds.

Liver Applications

Diet-induced Steatosis

Extend your assay window for efficacy testing of anti-steatotic drugs

Liver Fibrosis

Test efficacy of anti-fibrotic drugs in an advanced 3D liver disease model


Test efficacy of anti-NASH drugs in an advanced 3D liver disease model

InSphero Solutions

Microtissue Models and Kits

Request Additional Resources

Brochure: Solutions for Toxicology


Poster: Drug Safety Assessment with Liver Microtissues


Brochure: Human Liver Fibrosis Model


Find out how you can accelerate NASH drug discovery

with more relevant liver disease models.

Get Started